Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
$17.65
-$1.58(-8.22%)
SNDXSyndax Pharmaceuticals
$17.65
-$1.58 (-8.22%)

Syndax Pharmaceuticals Stock Analysis & Ratings

Syndax Pharmaceuticals Stock Analysis Overview

Smart Score
7
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Syndax Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, Data-Driven rating system and does not include human intervention.

Stock Chart

SNDX
$17.65
-$1.58 (-8.22%)

SNDX Stock Stats

Previous Close$19.23
Open$19.24
Bid17.66 x 1
Ask19 x 5
Today’s Range$17.53 - $19.24
52-Week Range$13.02 - $27.85
Volume368.66K
Average Volume818.94K
Market Cap$851.59M
Beta1.64
P/E Ratio-10.3
EPS-1.86
Earnings DateAug 10, 2021

Company Description

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
Sector
Healthcare
Industry
Biotechnology
CEO
Briggs W. Morrison
Employees
43
Address
35 Gatehouse Drive, Waltham, MA, 02451, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

SNDX FAQ

What was Syndax Pharmaceuticals’s price range in the past 12 months?
Syndax Pharmaceuticals lowest stock price was $13.02 and its highest was $27.85 in the past 12 months.
What is Syndax Pharmaceuticals’s market cap?
Syndax Pharmaceuticals’s market cap is $851.59M.
What is Syndax Pharmaceuticals’s price target?
The average price target for Syndax Pharmaceuticals is $27.40. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $32.00 ,the lowest forecast is $20.00. The average price target represents 55.24% Increase from the current price of $17.65.
What do analysts say about Syndax Pharmaceuticals?
Syndax Pharmaceuticals’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
When is Syndax Pharmaceuticals’s upcoming earnings report date?
Syndax Pharmaceuticals’s upcoming earnings report date is Aug 10, 2021 which is next month.
How were Syndax Pharmaceuticals’s earnings last quarter?
Syndax Pharmaceuticals released its earnings results on May 11, 2021. The company reported -$0.538 earnings per share for the quarter, beating the consensus estimate of -$0.649 by $0.111.
Is Syndax Pharmaceuticals overvalued?
According to Wall Street analysts Syndax Pharmaceuticals’s price is currently Undervalued.
Does Syndax Pharmaceuticals pay dividends?
Syndax Pharmaceuticals does not currently pay dividends.
What is Syndax Pharmaceuticals’s EPS estimate?
Syndax Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syndax Pharmaceuticals have?
Syndax Pharmaceuticals has 48,250,000 shares outstanding.
What happened to Syndax Pharmaceuticals’s price movement after its last earnings report?
Syndax Pharmaceuticals reported an EPS of -$0.538 in its last earnings report, beating expectations of -$0.649. Following the earnings report the stock price went up 14.578%.
Which hedge fund is a major shareholder of Syndax Pharmaceuticals?
Among the largest hedge funds holding Syndax Pharmaceuticals’s share is HealthCor Management, L.P.. It holds Syndax Pharmaceuticals’s shares valued at 31M.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis